In the age of covid-19, digital devices worn by patients are increasingly being piloted to monitor those who […]
Month: February 2021
It looks like a world beating performance—the United Kingdom has administered more covid-19 vaccine first doses per 100 […]
New report recommends continuing collaborations across the life sciences sector
In the HER2CLIMB trial, Tukysa-treated patients had a 46% reduction in the risk of cancer progression or death
Series C financing will also be used for the development of Evox’s DeliverEX exosome drug platform
Funding will be given to four long COVID research studies
Updated Date: Wed, 10 Feb 2021 00:00:00 EST
Updated Date: Wed, 10 Feb 2021 00:00:00 EST
Data favor Merck, Eisai’s Keytruda-Lenvima as the winner in kidney cancer, but window still open for Bristol Myers: […]
Study reveals the unintended and negative consequences of policies designed to reduce the supply of opioids in the […]